BioCentury | May 1, 2014
Distillery Therapeutics

Indication: Neurology

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Stroke Arachidonate 15-lipoxygenase (ALOX15; 15-LOX) In...
BioCentury | Jan 28, 2013
Company News

Orexo, AstraZeneca deal

...rights to develop and commercialize Orexo's OX-CLI and OX-ESI programs. The OX-ESI compounds inhibit arachidonate 15-lipoxygenase...
BioCentury | Jan 26, 2013
Company News

AstraZeneca gets option to preclinical Orexo program

...rights to develop and commercialize Orexo's OX-CLI and OX-ESI programs. The OX-ESI compounds inhibit arachidonate 15-lipoxygenase...
BioCentury | Apr 26, 2012
Distillery Therapeutics

Indication: Autoimmune disease

...therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Autoimmune disease Arachidonate 15-lipoxygenase...
BioCentury | Feb 6, 2012
Company News

Orexo, J&J deal

...due to lack of funding. The compounds, which inhibit leukotriene C4 synthase (LTC4S) and arachidonate 15-lipoxygenase...
BioCentury | May 12, 2011
Distillery Therapeutics

Indication: Cancer

...in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Arachidonate 15-lipoxygenase...
BioCentury | Jun 7, 2010
Company News

Orexo, J&J deal

...and commercialize OX-CLI and OX-ESI. The compounds, which inhibit leukotriene C4 synthase (LTC4S) and arachidonate 15-lipoxygenase...
BioCentury | Jun 7, 2010
Strategy

J&J's Pulmonary Push

...an undisclosed target. The OX-CLI and OX-ESI programs inhibit leukotriene C4 synthase (LTC4S) and arachidonate 15-lipoxygenase...
...in lung tissue among smokers and patients with bronchitis or asthma than among healthy non-smokers. 15-lipoxygenase...
BioCentury | Jun 2, 2010
Company News

J&J units in pulmonary deals

...and commercialize OX-CLI and OX-ESI. The compounds, which inhibit leukotriene C4 synthase (LTC4S) and arachidonate 15-lipoxygenase...
BioCentury | Jul 9, 2009
Distillery Therapeutics

Indication: Cardiovascular disease

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Heart failure Arachidonate 15-lipoxygenase (Alox15...
Items per page:
1 - 10 of 14